Incidence of the involvement of the cardiovascular system in HIV infection.
The epidemiology of cardiac complications related to HIV, including cardiomyopathy, increased left ventricular mass, myocarditis, pericardial effusion, endocarditis, and malignancy, are discussed. An increased number of HIV-infected individuals may present with cardiac complications in the next decade as chronic viral infection, co-infections, drug therapy, and immunosuppression affect the heart. Understanding the nature and course of cardiac illness related to HIV infection may allow appropriate monitoring, early intervention and therapy, and will provide a baseline to evaluate the effects of new therapeutic regimens such as highly active antiretroviral therapy on the cardiovascular system.
Barbarinia
Giorgio
G
Department of Infectious and Tropical Diseases, Policlinico S. Matteo, University of Pavia, Italy.
Barbaro
Giuseppe
G
D017088:AIDS-Related Opportunistic Infections; D002311:Cardiomyopathy, Dilated / Q000821:virology; D003324:Coronary Artery Disease / Q000821:virology; D004696:Endocarditis / Q000821:virology; D015658:HIV Infections / Q000150:complications*; D006330:Heart Defects, Congenital / Q000821:virology; D006331:Heart Diseases / Q000821:virology*; D006338:Heart Neoplasms / Q000821:virology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000821:virology; D009205:Myocarditis / Q000821:virology; D010490:Pericardial Effusion / Q000821:virology; D018497:Ventricular Dysfunction, Right / Q000821:virology